A clinical review confirms that cannabinoid hyperemesis syndrome prevalence reaches approximately one-third of regular cannabis users. The condition presents with characteristic recurrent vomiting episodes and the distinctive finding of temporary relief with hot water exposure, making it an important consideration for clinicians managing cannabis patients.
In the Mix: 7 More Articles — April 14, 2026
In the Mix — Last 24 HoursApril 14, 2026. 7 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25CATHAROS launches: Germany's local marketplace for...
CannaLnx Expands Insured Medical Cannabis Access Across California with 9 Retail and …
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CannalnxExpandsInsuredMedical Why This MattersThis item covers developments relevant to cannabis medicine and clinical practice....
Trulieve to Open Medical Cannabis Dispensary in Boca Raton, Florida – Seeking Alpha
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic TrulieveOpenMedicalCannabis Why This MattersThis item covers developments relevant to cannabis medicine and clinical practice....
Cannabis companies once poured millions into Hartford—now they’re pulling back – CT Insider
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CannabisCompaniesOncePoured Why This MattersThis item covers developments relevant to cannabis medicine and clinical practice....
Mike Tyson, Veterans Cannabis Care Partner to Fund Medical Cannabis Access – mg Magazine
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic MikeTysonVeteransCannabis Why This MattersThis item covers developments relevant to cannabis medicine and clinical practice....
High Tide to Present at Several Major International Cannabis and Investor Conferences
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic IndustryBusinessInvestmentCannabis Market Why This MattersCorporate cannabis conference presentations reflect industry maturation and investor interest,...
Policy Watch: 10 Regulatory Updates — April 12, 2026
Policy WatchApril 12, 2026. 10 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Federal...
New cannabis models under the microscope: less illegal sales, but at what price?
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic NewCannabisModelsUnder Why This MattersThis item covers developments relevant to cannabis medicine and clinical practice....
Judge temporarily blocks Texas ban on smokable THC products – FOX 7 Austin
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyHempThcRegulationTexas Why This MattersLegal uncertainty around smokable hemp-derived THC products creates immediate clinical challenges...